Steroid responsiveness and wheezing phenotypes

Paediatric Respiratory Reviews

Volumn 12, Issue 3, 2011, Pages 170-176

  Ducharme, Francine M ^a,b,c   Krajinovic, Maja ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Adrenal cortex hormones; Asthma; Child; Genotype; Inflammation; Phenotype; Respiratory tract infections; Tobacco smoke pollution

Indexed keywords

ADRENALIN; BUDESONIDE; CD14 ANTIGEN; CORTICOSTEROID; DEXAMETHASONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PLACEBO; PREDNISOLONE; PREDNISONE; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC RHINITIS; ASTHMA; BRONCHIOLITIS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENVIRONMENTAL EXPOSURE; EOSINOPHIL; EOSINOPHILIA; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LOW DRUG DOSE; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; WHEEZING;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; GENOTYPE; GLUCOCORTICOIDS; HUMANS; PHENOTYPE; RESPIRATORY SOUNDS; TOBACCO SMOKE POLLUTION;

EID: 79959709446     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2011.02.007     Document Type: Review

References (56)

1. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention Global Initiative for Asthma. [updated 2009 December 1; cited 2011 Jan 3]. Available from: http://www.ginasthma.org/.
2. Panickar J., Lakhanpaul M., Lambert P.C., Kenia P., Stephenson T., Smyth A., et al. Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med 2009, 360:329-338.
3. McKean M., Ducharme F. Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database System Rev 2000, 2. CD001107.
4. Ducharme F.M., Lemire C., Noya F.J., Davis G.M., Alos N., Leblond H., et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 2009, 360:339-353.
5. Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA). [updated 2008; cited 2009 Jul 3]. Available from: http://www.ginasthma.org/.
6. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guidelines on the management of asthma - A national clinical guideline British Thoracic Society. [updated 2009; cited 2011 Jan 3]. Available from: http://www.brit-thoracic.org.uk/clinical-information/asthma/asthma-guidelines.aspx.
7. Bacharier L.B., Boner A., Carlsen K.H., Eigenmann P.A., Frischer T., Gotz M., et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008, 63:5-34.
8. Myers T.R. Pediatric asthma epidemiology: incidence, morbidity, and mortality. Respir Care Clin N Am 2000, 6:1-14.
9. Martinez F.D., Wright A.L., Taussig L.M., Holberg C.J., Halonen M., Morgan W.J. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. New Engl J Med 1995, 332:133-138.
10. American Academy of Pediatrics Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis. Pediatrics 2006;118:1774-93.
11. Corneli H.M., Zorc J.J., Mahajan P., Shaw K.N., Holubkov R., Reeves S.D., et al. A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis. N Engl J Med 2007, 357:331-339.
12. Plint A.C., Johnson D.W., Patel H., Wiebe N., Correll R., Brant R., et al. Epinephrine and dexamethasone in children with bronchiolitis.[see comment]. New Engl J Med 2009, 360:2079-2089.
13. Ducharme F.M., Zemek R.L., Schuh S. Oral corticosteroids in children with wheezing. N Engl J Med 2009, 360:1674.
14. Brand P.L.P., Baraldi E., Bisgaard H., Boner A.L., Castro-Rodriguez J.A., Custovic A., et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008, 32:1096-1110.
15. Pauwels R.A., Pedersen S., Busse W.W., Tan W.C., Chen Y.Z., Ohlsson S.V., et al. Early intervention with budesonide in mild persistent asthma: A randomised, double-blind trial. Lancet 2003, 361:1071-1076.
16. Ducharme F.M., Di Salvio F. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. Cochrane Database System Rev 2004, CD002314.
17. Adams N.P., Bestall J.C., Jones P.W., Lasserson T.J., Griffiths B., Cates C. Inhaled fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev 2005, CD003534.
18. Guilbert T.W., Morgan W.J., Zeiger R.S., Mauger D.T., Boehmer S.J., Szefler S.J., et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. New Engl J Med 2006, 354:1985-1997.
19. Wilson N., Sloper K., Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Arch Dis Child 1995, 72:317-320.
20. Bisgaard H., Zielen S., Garcia-Garcia M.L., Johnston S.L., Gilles L., Menten J., et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005, 171:315-322.
21. National Heart Lung and Blood Institute. Global initiative for asthma. Global strategy for asthma management and prevention. NHLBI/WHO workshop report. Bethesda, MD: NIH; 2002. Report No.: NIH publication No 02-3659.
22. Lemiere C., Bai T., Baltzan M., Bayliff C., Becker A., Boulet L.P., et al. Adult Asthma Consensus Guidelines Update 2003. Can Respir J 2004, 11:9a-18a. On behalf of the Canadian Asthma Consensus Group of the Canadian Thoracic Society.
23. Bousquet J., Clark T.J., Hurd S., Khaltaev N., Lenfant C., O'Byrne P., et al. GINA guidelines on asthma and beyond. Allergy 2007, 62:102-112.
24. Lougheed M.D., Lemiere C., Dell S.D., Ducharme F.M., Fitzgerald J.M., Leigh R., et al. Canadian Thoracic Society Asthma Management Continuum - 2010 Consensus Summary for children six years of age and over, and adults. Can Respir J 2010, 17:15-24.
25. Quon BS, Fitzgerald JM, Lemiere C, Shahidi N, Ducharme FM. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. [Review]. Cochrane Database of Systematic Reviews (10):CD007524, 2010 2010;CD007524.
26. Bacharier L.B., Phillips B.R., Zeiger R.S., Szefler S.J., Martinez F.D., Lemanske R.F., et al. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol 2008, 122:1127-1135.
27. Bacharier L.B., Guilbert T.W., Zeiger R.S., Strunk R.C., Morgan W.J., Lemanske R.F., et al. Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. J Allergy Clin Immunol 2010, 123:1077-1082.
28. Zhang L., Axelsson I., Chung M., Lau J. Dose Response of Inhaled Corticosteroids in Children With Persistent Asthma: A Systematic Review. Pediatrics 2011, 127:129-138.
29. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Lampe F., Josephs L., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Brit Med J 1995, 310:1225-1229.
30. Plotnick L., Ducharme F.M. Should inhaled anticholinergics be added to beta2-agonists in acute pediatric asthma? A systematic review of randomized controlled trials. British Medical Journal 1998, 317:971-977.
31. Rowe B.H., Spooner C., Ducharme F.M., Bretzlaff J.A., Bota G.W. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2001, 1:CD002178.
32. Vuillermin P., South M., Robertson C. Parent-initiated oral corticosteroid therapy for intermittent wheezing illnesses in children. Cochrane Database Syst Rev 2006, 3:CD005311.
33. Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Campbell M.J., Josephs L.K., et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996, 154. t-60.
34. Heymann P.W., Platts-Mills T.A., Johnston S.L. Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults. Pediatr Infect Dis J 2005, 24:S217-S222.
35. Wark P.A., Johnston S.L., Moric I., Simpson J.L., Hensley M.J., Gibson P.G. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 2002, 19:68-75.
36. Jartti T., Lehtinen P., Vanto T., Hartiala J., Vuorinen T., Makela M.J., et al. Evaluation of the Efficacy of Prednisolone in Early Wheezing Induced by Rhinovirus or Respiratory Syncytial Virus. [Article]. Pediatr Infect Dis J 2006, 25:482-488.
37. Jartti T., Lehtinen P., Vanto T., Vuorinen T., Hartiala J., Hiekkanen H., et al. Efficacy of prednisolone in children hospitalized for recurrent wheezing. Pediatr Allergy Immunol 2007, 18:326-334.
38. Chaudhuri R., Livingston E., McMahon A.D., Thomson L., Borland W., Thomson N.C. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma.[see comment]. Am J Respir Crit Care Med 2003, 168:1308-1311.
39. Chalmers G.W., MacLeod K.J., Little S.A., Thomson L.J., McSharry C.P., Thomson N.C. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002, 57:226-230.
40. Chilmonczyk B.A., Salmun L.M., Megathlin K.N., Neveux L.M., Palomaki G.E., Knight G.J., et al. Association between exposure to environmental tobacco smoke and exacerbations of asthma in children [see comments]. New Engl J Med 1993, 328:1665-1669.
41. Chang M.Y., Hogan A.D., Rakes G.P., Ingram J.M., Hoover G.E., PlattsMills T.A., et al. Salivary cotinine levels in children presenting with wheezing to an emergency department. Pediatr Pulmonol 2000, 29:257-263.
42. Wark P.A., Gibson P.G., Johnston S.L. Exacerbations of asthma: addressing the triggers and treatments. Monaldi Arch Chest Dis 2001, 56:429-435.
43. Bouzigon E., Corda E., Aschard H., Dizier M.H., Boland A., Bousquet J., et al. Effect of 17q21 variants and smoking exposure in early-onset asthma.[see comment]. New Engl J Med 2008, 359:1985-1994.
44. Sharma S., Raby B.A., Hunninghake G.M., Soto-Quiros M., Avila L., Murphy A.J., et al. Variants in TGFB1, dust mite exposure, and disease severity in children with asthma. Am J Respir Crit Care Med 2009, 179:356-362.
45. Laing I.A., de Klerk N.H., Turner S.W., Judge P.K., Hayden C.M., Landau L.I., et al. Cross-sectional and longitudinal association of the secretoglobin 1A1 gene A38G polymorphism with asthma phenotype in the Perth Infant Asthma Follow-up cohort. Clin Exp Allergy 2009, 39:62-71.
46. Zhou H., Alexis N., Almond M., Donohue J., LaForce C., Bromberg P., et al. Influence of C-159T SNP of the CD14 gene promoter on lung function in smokers. Respir Med 2009, 103:1358-1365.
47. Moffatt M.F., Kabesch M., Liang L., Dixon A.L., Strachan D., Heath S., et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007, 448:470-473.
48. Tamer L., Calikoglu M., Ates N.A., Yildirim H., Ercan B., Saritas E., et al. Glutathione-S-transferase gene polymorphisms (GSTT1, GSTM1, GSTP1) as increased risk factors for asthma. Respirology 2004, 9:493-498.
49. He J.Q., Ruan J., Connett J.E., Anthonisen N.R., Pare P.D., Sandford A.J. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med 2002, 166:323-328.
50. Wang C., Salam M.T., Islam T., Wenten M., Gauderman W.J., Gilliland F.D. Effects of in utero and childhood tobacco smoke exposure and beta2-adrenergic receptor genotype on childhood asthma and wheezing. Pediatrics 2008, 122:e107-e114.
51. Tantisira K.G., Lake S., Silverman E.S., Palmer L.J., Lazarus R., Silverman E.K., et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Human Molecular Genetics 2004, 13:1353-1359.
52. Tantisira K.G., Hwang E.S., Raby B.A., Silverman E.S., Lake S.L., Richter B.G., et al. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:18099-18104.
53. Tantisira K.G., Silverman E.S., Mariani T.J., Xu J., Richter B.G., Klanderman B.J., et al. FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma. J Allergy Clin Immunol 2007, 120:1285-1291.
54. Gibson P.G., Norzila M.Z., Fakes K., Simpson J., Henry R.L. Pattern of airway inflammation and its determinants in children with acute severe asthma. Pediatr Pulmonol 1999, 28:261-270.
55. Pizzichini M.M., Pizzichini E., Efthimiadis A., Chauhan A.J., Johnston S.L., Hussack P., et al. Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med 1998, 158:1178-1184.
56. Pavord I.D., Shaw D.E., Gibson P.G., Taylor D.R. Inflammometry to assess airway diseases. Lancet 2008, 372:1017-1019.